Amniotic Fluid: Composition, Functions, and Clinical Disorders

Amniotic fluid (AF) is a dynamic fetal compartment essential for development. Volume peaks at approximately 800–1000 mL around 34–36 weeks, then declines to roughly 600 mL at term.

Composition (Evolving with Gestation)

  • Early (<20 weeks): Transudate of maternal and fetal plasma—98% water, electrolytes, proteins, carbohydrates, lipids.
  • Mid-to-late gestation: Fetal urine becomes the primary source (increasing urea, creatinine, uric acid); supplemented by lung fluid, vernix, lanugo, desquamated cells, antimicrobial peptides (defensins), growth factors (EGF, TGF-β), and stem cells.

Physiologic Functions

FunctionMechanism
Mechanical protectionCushions trauma; distributes force; prevents uterine wall adhesion
ThermoregulationMaintains stable temperature (±0.5°C)
Musculoskeletal developmentProvides space for movement → joint formation, muscle tone, chest wall compliance
Pulmonary developmentFetal breathing movements → lung expansion, surfactant production, alveolarization
Gastrointestinal maturationSwallowing (200–750 mL/day) → gut priming, fluid balance
Chemical signalingGrowth factors, cytokines, hormones regulate fetal/organ maturation
Infection barrierAntimicrobial peptides, IgA, complement; physical seal after membrane rupture

Clinical Disorders

Oligohydramnios (AFI <5 cm or Maximum Vertical Pocket <2 cm)

  • Causes: Preterm premature rupture of membranes (PPROM), placental insufficiency, renal agenesis/dysplasia, obstructive uropathy, post-dates pregnancy, medications (ACE inhibitors, ARBs, NSAIDs).
  • Risks: Pulmonary hypoplasia, limb contractures (Potter sequence), cord compression, fetal growth restriction, cesarean delivery for non-reassuring fetal status.
  • Management: Serial AFI monitoring, maternal hydration, amnioinfusion during labor, delivery timing based on gestational age.

Polyhydramnios (AFI >24 cm or Maximum Vertical Pocket >8 cm)

  • Causes: Fetal anomalies (esophageal/duodenal atresia, anencephaly, CNS anomalies), maternal diabetes, twin-twin transfusion syndrome (monochorionic twins), infections (parvovirus, syphilis), idiopathic (~60%).
  • Risks: Preterm labor, malpresentation, cord prolapse, placental abruption, postpartum hemorrhage.
  • Management: Targeted anatomy scan, glucose tolerance testing, karyotype/chromosomal microarray, amnioreduction if symptomatic, treat underlying cause.

Diagnostic Amniocentesis

  • Genetic: Karyotype, chromosomal microarray, exome sequencing (typically 15–20 weeks).
  • Infection: PCR for CMV, toxoplasmosis, parvovirus, Zika.
  • Fetal lung maturity: L/S ratio, phosphatidylglycerol, lamellar body count (rarely needed currently).
  • Therapeutic: Amnioreduction, intrauterine transfusion, fetal surgery access.

Amniotic fluid volume and composition serve as windows into fetal well-being; serial ultrasound assessment remains the standard of care.

Infertility - Related Articles